Johnson & Johnson will invest $55 billion in U.S. manufacturing, research and technology over the next four years, marking a 25% increase in investment for the company.
The expansion will include four new manufacturing facilities, with the first breaking ground March 21 in Wilson, N.C., according to a March 21 news release from the company.
The 500,000-square-foot biologics plant is expected to create 500 permanent jobs and support 5,000 construction jobs.
Beyond North Carolina, J&J plans to expand on existing facilities and invest in oncology, neuroscience, immunology, cardiovascular treatments and robotic surgery. The company’s total economic U.S. impact is estimated at over $100 billion annually, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.